Information  X 
Enter a valid email address

Broker Forecast - Morgan Stanley issues a broker note on Hikma Pharmaceuticals PLC

By BFN News | 11:00 AM | Tuesday 07 July, 2020


Morgan Stanley today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to overweight (from equal weight) and raised its price target to 2600p (from 2200p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t